La impotencia de origen orgánico —disfunción eréctil (DE) derivada de una causa física— se define como la incapacidad consistente o recurrente de lograr y/o mantener una erección peneana suficiente para un rendimiento sexual satisfactorio. El tratamiento de primera línea sigue un protocolo estructurado y basado en evidencia que combina intervenciones conductuales y farmacológicas.
DOI: 10.1016/j.juro.2018.05.004
Erectile dysfunction (ED) can be conceptualized as an impairment in the arousal phase of sexual response and is defined as the consistent or recurrent inability to attain and/or maintain penile erection sufficient for sexual satisfaction, including satisfactory sexual performance.
Clinicians should counsel men with ED who have comorbidities known to negatively affect erectile function that lifestyle modifications, including changes in diet and increased physical activity, improve overall health and may improve erectile function.
Men with ED should be informed regarding the treatment option of an FDA-approved oral phosphodiesterase type 5 inhibitor (PDE5i), including discussion of benefits and risks/burdens, unless contraindicated.
For men who are prescribed PDE5i, the dose should be titrated to provide optimal efficacy.
View source ↗